scholarly journals Homeopathy as an alternative for asthma treatment

2021 ◽  
Vol 10 (36) ◽  
pp. 201-202
Author(s):  
Cassia Virginia Garcia ◽  
Gabriela Veiga Vieira Mancio Bandeira ◽  
Andreas Sebastian Loureiro Mendez
Keyword(s):  
Adverse Effects ◽  
Lifestyle Modification ◽  
Chronic Inflammatory Disease ◽  
Traditional Therapy ◽  
Homeopathic Treatment ◽  
Alternative Medicines ◽  
Asthma Patients ◽  
Emotional Component

Background: Asthma is a chronic inflammatory disease characterized by a reversible obstruction and hyperactivity of inferior aerial treat [1]. It is responsible for lifestyle modification and, considering its high frequency, it became an important issue in the budget of health services around the world. Aspects like the lack of definitive results and presence of adverse effects, observed for traditional therapy, as well as the search for better quality of life have increased patients’ interest for complementary and alternative medicines (CAM), being homeopathy one of the most cited [2]. In 2001, asthma was between the 10 diagnostics most treated by homeopaths in USA [3]. Aims: In this work, a qualitative research was made focusing the evaluation of the real contribution that homeopathy can represent for asthma patients and the role of pharmacist in this therapy. Methodology: databases such as Medline, Sciencedirect and Bireme were used to find scientific articles, applying the expressions “asthma”, “homeopathy” and “complementary and alternative medicine”. Results: At least six works demonstrate successful applications of homeopathic treatment in children or adults with asthma. The main benefits cited are the decrease of frequency and gravity of the crises, besides of some cure cases. Conclusions: Data available are still scanty about asthma homeopathic treatment. The few works found showed this kind of therapy is very adequate, mainly because of the emotional component of the disease, but also because it represents to be away from the adverse effects commonly related to the traditional therapy (e. g. corticoids). To ensure a correct therapy is being made, the pharmacist must be present and active in the patients’ identification and documentation, giving them right orientations about the use and storage of homeopathic medicines, besides of stimulating a close and confidence relationship with the homeopath. Also, the manufacturing of remedies must be according to the official guidelines in order to guarantee their quality.

scholarly journals Treatment strategies for chemotherapy-induced peripheral neuropathy: potential role of exercise

2011 ◽  
Vol 4 (2) ◽  
pp. 117
Author(s):  
Karen Y. Wonders ◽  
Beverly S. Reigle ◽  
Daniel G. Drury
Keyword(s):  
Quality Of Life ◽  
Peripheral Neuropathy ◽  
Cancer Patients ◽  
Lifestyle Modification ◽  
Treatment Strategies ◽  
Moderate Intensity ◽  
Moderate Intensity Exercise ◽  
Exercise Rehabilitation

Chemotherapy-induced peripheral neuropathy (CIPN) is a common, dose-limiting effect of cancer therapy that often has negative implications on a patient’s quality of life. The pain associated with CIPN has long been recognized as one of the most difficult types of pain to treat. Historically, much effort has been made to explore pharmacological therapies aimed at reducing symptoms of CIPN. While many of these agents provide a modest relief in the symptoms of peripheral neuropathy, many have been shown to have additional negative side effects for cancer patients. Therefore, the authors suggest exercise rehabilitation as one lifestyle modification that may positively impact the lives of patients with CIPN. To our knowledge, there are currently no published clinical trials examining the role of exercise in preserving neurological function following chemotherapy. However, investigations using low-to-moderate intensity exercise as an intervention in patients with diabetic peripheral neuropathy and hereditary motor and sensory neuropathies have produced promising results. Given that cancer patients appear to tolerate exercise, it seems plausible that exercise rehabilitation could be used as an effective strategy to minimize CIPN-induced detriments to quality of life.

Considerations on the Use of Aromatase Inhibitors in Postmenopausal Women With Breast Cancer

2020 ◽  
pp. 385-400
Author(s):  
Jeffrey D. Blaustein
Keyword(s):  
Breast Cancer ◽  
Quality Of Life ◽  
Cognitive Function ◽  
Adverse Effects ◽  
Develop Breast Cancer ◽  
Laboratory Animals ◽  
Breast Cancers ◽  
The Brain

About 1 of every 8 women will develop breast cancer during her lifetime, and approximately 250,000 new cancer cases are expected annually as of 2017. Of those breast cancers, approximately 60% to 75% will express estrogen receptors, suggesting that estrogens are likely to promote growth of those tumors. Because the use of inhibitors of the synthesis of estrogens is the adjuvant treatment of choice for many women, it is essential that we understand the potential adverse effects on quality of life of those treatments. This review addresses the role of estrogens locally synthesized in the brain in laboratory animals and women, the effects of estrogens on cognitive function, the effects of synthesis blockers on cognitive function, and the limitations in performing experiments that will give us strong confidence in the results and conclusions.

Effect of Exercise on Asthma from Iranian Traditional Medicine Perspective

2019 ◽  
Author(s):  
Saeed Sadr ◽  
Narges Kaveh ◽  
Rasool Choopani ◽  
Shahpar Kaveh ◽  
Sohrab Dehghan
Keyword(s):  
Traditional Medicine ◽  
Conventional Medicine ◽  
Chronic Inflammatory Disease ◽  
The Body ◽  
Iranian Traditional Medicine ◽  
Respiratory Parameters ◽  
Asthma Patients ◽  
Included Review ◽  
Body Heat

Asthma is a chronic inflammatory disease of the airways. In the conventional medicine, in addition drug therapy, exercise can also improve the respiratory parameters in asthma. In this article the view of Iranian Traditional Medicine (Persian Medicine) scholars on the effect of exercise in asthma is discussed. In this review article subjects related to exercise and asthma by two words ‘‘Riyazat’’ and ‘‘Rabv balghami’’ are collected from the major references of Iranian Traditional Medicine (ITM) such as Al- Havi, Cannon of medicine, Zakhireh kharazmshahi, Tibbe Akbari, Kholasat al-hekmat, Mojarabat, Al-mokhtarat fi al-tib and Exire Aazam. Many relevant abstracts and articles in the above mentioned areas were selected from Pub Med and Google Scholar which were published during 2003 to 2015. Articles selected for detailed review included review articles and clinical trial studies in humans. In ITM, Asthma is caused due to accumulation of thick secretions (Balghame ghaliz) in the airways. Exercise is recommended as an adjuvant therapy for asthma. In ITM’s view, exercise followed in proper manner, increases the body heat which by diluting the secretions helps the process of expulsion. In ITM, Exercise has an assisting role in the management of asthma, in other words following recommended exercises in their proper conditions can result in improved respiratory functions in patients. Ultimately, ITM recommendations along with modern medical management can improve the quality of life in asthma patients, an interesting subject that demands further research in the future.

scholarly journals Role of Montelukast in Asthma and Allergic rhinitis patients

2020 ◽  
Vol 36 (7) ◽  
Author(s):  
Faisal Faiyaz Zuberi ◽  
Muhammad Amir Haroon ◽  
Abdul Haseeb ◽  
Shafi Muhammad Khuhawar
Keyword(s):  
Allergic Rhinitis ◽  
Adverse Effects ◽  
Upper Respiratory Tract ◽  
Open Label ◽  
Night Time ◽  
Creative Commons ◽  
The Individual

Objectives: Our objective was to evaluate the effect of Montelukast on the symptoms of asthma and allergic rhinitis (AR), assess its effect on the individual quality of life (QoL), and estimate the proportion of participants having adverse effects. Methods: This prospective, open-label study conducted at Dow University of Health Sciences, Ankle Saria Hospital and Sindh Government Hospital Liaquatabad, Karachi, from August 2018 to September 2019, included patients aged >18 years with a clinical diagnosis of Asthma, AR, or both. Patients were given a 10 mg Montelukast tablet each day and then called for follow-up in the fourth week, where the questions related to the improvement in the symptoms of asthma or AR were asked. Patients were also asked about the improvement in QoL and any adverse effects. Results: A total of 694 patients were registered of which 138(19.8%) had AR, 294(42.4%) had asthma, while 273(39.3%) had both. Mean age was 41.1±14.63 years and 352 (50.7%) were male and 342(49.3%) were females. On a follow-up visit, there was a sufficient improvement in 351 asthmatics (63.9%), and 288 patients with AR (70.1%) overall, strong or marked improvement in the day (n=342,62.3%) and night time (n=331,60.3%) asthma symptoms. Overall improvements in QoL were very good or good in 419 patients. Montelukast was well-tolerated here with adverse effects (like abdominal discomfort, fever, fatigue, headache, rash, and upper respiratory tract symptoms) seen in 125 patients (18.01%). Conclusion: Montelukast was very effective in improving the symptoms and QoL of the individuals suffering from asthma and/or AR. doi: https://doi.org/10.12669/pjms.36.7.2657 How to cite this:Zuberi FF, Haroon MA, Haseeb A, Khuhawar SM. Role of Montelukast in Asthma and Allergic rhinitis patients. Pak J Med Sci. 2020;36(7):---------. doi: https://doi.org/10.12669/pjms.36.7.2657 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/3.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Surgical Management of Ulcerative Colitis

2017 ◽  
Author(s):  
Amy Lightner ◽  
Robert R. Cima ◽  
John H. Pemberton
Keyword(s):  
Ulcerative Colitis ◽  
Crohn Disease ◽  
De Novo ◽  
Symptom Control ◽  
Chronic Inflammatory Disease ◽  
Pelvic Sepsis ◽  
Anal Stricture ◽  
Inflammatory Bowel

Inflammatory bowel disease is a chronic inflammatory disease of the intestine that can be divided into two main categories: Crohn disease and chronic ulcerative colitis (CUC). Although the role of medical therapy in CUC is directed at symptom control or the underlying inflammatory process, fortunately, the intestinal manifestations of CUC can be effectively cured by surgery. The operation of choice is an ileal pouch-anal anastomosis (IPAA), which can be performed open or laparoscopically, with a hand-sewn or stapled anastomosis, or in a one-, two-, or three-stage fashion. Although pouch function and quality of life remain good following IPAA, common complications include pouchitis, anal stricture, pouch fistulas, and small bowel obstructions. The most dreaded complication is an anastomotic leak resulting in pelvic sepsis and, often, eventual pouch excision. Less common complications include pouch dysplasia or cancer and de novo Crohn disease of the pouch. Overall, regardless of age, patient satisfaction following IPAA remains high, and more than 90% of patients retain their pouches for more than 20 years.  This review contains 11 highly rendered figures, and 83 references.

Surgical Management of Ulcerative Colitis

2016 ◽  
Author(s):  
Amy Lightner ◽  
Robert R. Cima ◽  
John H. Pemberton
Keyword(s):  
Ulcerative Colitis ◽  
Crohn Disease ◽  
De Novo ◽  
Symptom Control ◽  
Chronic Inflammatory Disease ◽  
Pelvic Sepsis ◽  
Anal Stricture ◽  
Inflammatory Bowel

Inflammatory bowel disease is a chronic inflammatory disease of the intestine that can be divided into two main categories: Crohn disease and chronic ulcerative colitis (CUC). Although the role of medical therapy in CUC is directed at symptom control or the underlying inflammatory process, fortunately, the intestinal manifestations of CUC can be effectively cured by surgery. The operation of choice is an ileal pouch-anal anastomosis (IPAA), which can be performed open or laparoscopically, with a hand-sewn or stapled anastomosis, or in a one-, two-, or three-stage fashion. Although pouch function and quality of life remain good following IPAA, common complications include pouchitis, anal stricture, pouch fistulas, and small bowel obstructions. The most dreaded complication is an anastomotic leak resulting in pelvic sepsis and, often, eventual pouch excision. Less common complications include pouch dysplasia or cancer and de novo Crohn disease of the pouch. Overall, regardless of age, patient satisfaction following IPAA remains high, and more than 90% of patients retain their pouches for more than 20 years.  This review contains 11 highly rendered figures, and 83 references.

Cognitive Health Counseling 40+

2013 ◽  
Vol 21 (1) ◽  
pp. 24-33 ◽  
Author(s):  
Anne Eschen ◽  
Franzisca Zehnder ◽  
Mike Martin
Keyword(s):  
Outcome Variable ◽  
Pilot Phase ◽  
Subjective Memory ◽  
Cognitive Health ◽  
Health Counseling ◽  
Agents Of Change ◽  
Main Outcome Variable ◽  
Further Development

This article introduces Cognitive Health Counseling 40+ (CH.CO40+), an individualized intervention that is conceptually based on the orchestration model of quality-of-life management ( Martin & Kliegel, 2010 ) and aims at improving satisfaction with cognitive health in adults aged 40 years and older. We describe the theoretically deduced characteristics of CH.CO40+, its target group, its multifactorial nature, its individualization, the application of subjective and objective measures, the role of participants as agents of change, and the rationale for choosing participants’ satisfaction with their cognitive health as main outcome variable. A pilot phase with 15 middle-aged and six older adults suggests that CH.CO40+ attracts, and may be particularly suitable for, subjective memory complainers. Implications of the pilot data for the further development of the intervention are discussed.

Sign in / Sign up

Export Citation Format

Share Document